As we reported, the Canadian government has approved changes to Canada’s pharmaceutical patent regime, including the introduction of patent term restoration and the replacement of the current summary proceedings under the Patented Medicines (Notice of Compliance) Regulations with full actions.  The reforms were originally scheduled to come into force on July 1, 2017; however, the Government is now reporting a provisional application date of September 21, 2017.

Are you CETA ready?  Contact Norton Rose Fulbright with all your CETA questions. 



Bill-30, Third Reading (House of Commons)

Text of the final Comprehensive Economic and Trade Agreement